GSEI analysis in a NAFLD/NASH patient cohort shows a significant enrichment of regulation of Ang levels in blood and of cell response to Ang, indicating that Ang signaling is associated with liver disease progression in metabolic liver disease (Figure 7A). The gene discussed is ANG; the disease is metabolic dysfunction-associated steatotic liver disease.